chartexchange

MLYS
Mineralys Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:55 PM EDT
23.65USD-0.295%(-0.07)928,299
Pre-marketOct 2, 2026 9:07:26 AM EDT
23.76USD+0.169%(+0.04)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Radnor, PA, USA
Previous Close
$23.72
Beta
1.14
52-Week High
$47.65 2025-11-12
52-Week Low
$22.30 2026-06-08
SMA 50
$26.86
SMA 200
$28.42
Avg. Vol 10D
1.32M
Avg. Vol 30D
1.32M
Avg. Vol 90D
1.35M
Relative Vol
0.70
61.91M
0.3600%
2,500,000
781
Nov 9, 2026 (35d)
MLYS Profile

at mineralys therapeutics we aim to redefine hypertension diagnosis, management and treatment. we are driven to break the "trial and failure" approach to hypertension management and bring a personalized approach to the management of hypertension.

MLYS Performance
PeriodPriceDateChangeBeta
1W25.632026-09-28-7.72%0.056
1M28.212026-09-04-16.16%0.391
3M29.122026-07-06-18.78%0.485
6M28.232026-04-06-16.22%0.843
1Y38.062025-10-03-37.86%1.142
2Y13.882024-10-04+70.39%—
5Y18.442023-02-10+28.25%0.931
MLYS Stock Summary

Mineralys Therapeutics, Inc. Common Stock (NASDAQ:MLYS) stock price today is $23.65, and today's volume is 928,299. MLYS is down 0.295% today. The 30 day average volume is 1.32M. MLYS market cap is $2.09B with 88.41M shares outstanding.